课题基金 / 基金详情

ELLAGITANNINS & CANCER PREVENTION

ELLAGITANNINS & CANCER PREVENTION
鞣花单宁
批准号:
6265478
负责人:
DANIEL W NIXON
金额:
$1.74万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

DANIEL W NIXON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ellagic acid, a phenolic compound from the family of Ellagitannins, is naturally found in high concentrations in raspberries, strawberries, and walnuts. For the last 20 years ellagic acid and other ellagitannins have been shown to be effective chemopreventive agents in animal and cell models. The long term goal and objective of this study is to determine if the ellagitannins present in food sources can prevent cancer in humans. Before this can be done, the pharmacokinetic properties of the ellagic acid and the ellagitannins from food sources must be assessd. In the current study volunteers (12) will consume samples of raspberries, strawberries, and walnuts containing similar amounts of ellagitannins. Comparison of the serum and urine levels of ellagitannins will show which food provides the highest concentration of these compounds and is most suited for further study in human chemoprevention clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
START- STRATEGIC TIMING OF ANTIRETROVIRAL THERAPY
  • 批准号:
    8166579
  • 项目类别:
  • 资助金额:
    $0.07万
  • 财政年份:
    2009
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
STUDY A5235: A PHASE II, RANDOMIZED, DOUBLE-BLIND STUDY OF MINOCYCLINE IN THE
  • 批准号:
    8166560
  • 项目类别:
  • 资助金额:
    $1.02万
  • 财政年份:
    2009
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
CLINICAL TRIAL: A PHASE III COMPARATIVE STUDY OF THREE NON-NUCLEOSIDE REVERSE TR
  • 批准号:
    8166580
  • 项目类别:
  • 资助金额:
    $0.95万
  • 财政年份:
    2009
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
CLINICAL TRIAL: PHASE III STUDY OF SUBCUTANEOUS RECOMBINANT IL-2 IN PATIENTS W/
  • 批准号:
    7950848
  • 项目类别:
  • 资助金额:
    $4.15万
  • 财政年份:
    2008
  • 负责人:
    DANIEL W NIXON
  • 依托单位:
海外基金